Literature DB >> 11705634

MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease.

B C Dickerson1, I Goncharova, M P Sullivan, C Forchetti, R S Wilson, D A Bennett, L A Beckett, L deToledo-Morrell.   

Abstract

With high resolution, quantitative magnetic resonance imaging (MRI) techniques, it is now possible to examine alterations in brain anatomy in vivo and to identify regions affected in the earliest stages of Alzheimer's disease (AD). In this study, we compared MRI-derived entorhinal and hippocampal volume in healthy elderly controls, patients who presented at the clinic with cognitive complaints, but did not meet criteria for dementia (non-demented), and patients with very mild AD. The two patient groups differed significantly from controls in entorhinal volume, but not from each other; in contrast, they differed from each other, as well as from controls, in hippocampal volume, with the mild AD cases showing the greatest atrophy. Follow-up clinical evaluations available on 23/28 non-demented patients indicated that 12/23 had converted to AD within 12-77 months from the baseline MRI examination. Converters could be best differentiated from non-converters on the basis of entorhinal, but not hippocampal volume. These data suggest that although both the EC and hippocampal formation degenerate before the onset of overt dementia, EC volume is a better predictor of conversion.

Entities:  

Mesh:

Year:  2001        PMID: 11705634     DOI: 10.1016/s0197-4580(01)00271-8

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  180 in total

Review 1.  Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects.

Authors:  John Q Trojanowski; Hugo Vandeerstichele; Magdalena Korecka; Christopher M Clark; Paul S Aisen; Ronald C Petersen; Kaj Blennow; Holly Soares; Adam Simon; Piotr Lewczuk; Robert Dean; Eric Siemers; William Z Potter; Michael W Weiner; Clifford R Jack; William Jagust; Arthur W Toga; Virginia M-Y Lee; Leslie M Shaw
Journal:  Alzheimers Dement       Date:  2010-05       Impact factor: 21.566

2.  Medial temporal lobe function and structure in mild cognitive impairment.

Authors:  Bradford C Dickerson; David H Salat; Julianna F Bates; Monika Atiya; Ronald J Killiany; Douglas N Greve; Anders M Dale; Chantal E Stern; Deborah Blacker; Marilyn S Albert; Reisa A Sperling
Journal:  Ann Neurol       Date:  2004-07       Impact factor: 10.422

3.  The Cognitive Change in Women study (CCW): informant ratings of cognitive change but not self-ratings are associated with neuropsychological performance over 3 years.

Authors:  Rebecca Gavett; Julie E Dunn; Anne Stoddard; Brian Harty; Sandra Weintraub
Journal:  Alzheimer Dis Assoc Disord       Date:  2011 Oct-Dec       Impact factor: 2.703

4.  Hippocampal hyperactivation associated with cortical thinning in Alzheimer's disease signature regions in non-demented elderly adults.

Authors:  Deepti Putcha; Michael Brickhouse; Kelly O'Keefe; Caroline Sullivan; Dorene Rentz; Gad Marshall; Brad Dickerson; Reisa Sperling
Journal:  J Neurosci       Date:  2011-11-30       Impact factor: 6.167

5.  Event-related functional magnetic resonance imaging changes during relational retrieval in normal aging and amnestic mild cognitive impairment.

Authors:  Kelly S Giovanello; Felipe De Brigard; Jaclyn Hennessey Ford; Daniel I Kaufer; James R Burke; Jeffrey N Browndyke; Kathleen A Welsh-Bohmer
Journal:  J Int Neuropsychol Soc       Date:  2012-05-24       Impact factor: 2.892

6.  Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort.

Authors:  Shannon L Risacher; Li Shen; John D West; Sungeun Kim; Brenna C McDonald; Laurel A Beckett; Danielle J Harvey; Clifford R Jack; Michael W Weiner; Andrew J Saykin
Journal:  Neurobiol Aging       Date:  2010-08       Impact factor: 4.673

7.  Prediction of conversion from mild cognitive impairment to Alzheimer disease based on bayesian data mining with ensemble learning.

Authors:  R Chen; K Young; L L Chao; B Miller; K Yaffe; M W Weiner; E H Herskovits
Journal:  Neuroradiol J       Date:  2012-03-01

Review 8.  Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.

Authors:  Lisa Mosconi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-04       Impact factor: 9.236

9.  fMRI activation changes during successful episodic memory encoding and recognition in amnestic mild cognitive impairment relative to cognitively healthy older adults.

Authors:  Mehul A Trivedi; Christopher M Murphy; Celine Goetz; Raj C Shah; John D E Gabrieli; Susan Whitfield-Gabrieli; David A Turner; Glenn T Stebbins
Journal:  Dement Geriatr Cogn Disord       Date:  2008-07-28       Impact factor: 2.959

10.  Triple-transgenic Alzheimer's disease mice exhibit region-specific abnormalities in brain myelination patterns prior to appearance of amyloid and tau pathology.

Authors:  Maya K Desai; Kelly L Sudol; Michelle C Janelsins; Michael A Mastrangelo; Maria E Frazer; William J Bowers
Journal:  Glia       Date:  2009-01-01       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.